Amerityre a leading developer of polyurethane elastomer tire technologies, today announced that its Arcus(R) run-flat tire design has successfully completed all testing requirements under Federal Motor Vehicle Safety Standard (FMVSS) 139.
“Successful completion of FMVSS 139 testing on our Arcus(R) passenger car tire design has been a high priority for our company,” commented Dr. Gary N. Benninger, Amerityre’s President and Chief Executive Officer. “With the final endurance-phase testing successfully completed, we are now in a position to begin substantive discussions with companies that have expressed an interest in licensing our technology and to provide them with sample tires.”
According to Dr. Benninger, while companies are evaluating sample tires, Amerityre will focus on finishing the design and development of the manufacturing equipment required to produce the polyurethane road tire in commercial volumes. Amerityre’s tire manufacturing technology brings significant cost reductions to tire manufacturing. Amerityre estimates that the capital investment required for a potential manufacturer to produce one polyurethane passenger car tire per minute will be less than $10 million. This amount is one-sixth to one-eighth the cost of an equivalent rubber passenger car tire manufacturing line. Amerityre is discussing the construction and installation of a pilot manufacturing facility capable of demonstrating this production capability with potential strategic partners.
Through testing, Amerityre has previously shown that compared to rubber passenger car tires, polyurethane passenger car tires are capable of achieving longer life through improved durability, while their lower rolling resistance also reduces vehicle fuel consumption. Due to its chemical composition and the nature of its polymerization reaction, polyurethane is a much more environmentally friendly material than the rubber it replaces.
Amerityre is actively engaged in the development of revolutionary new polyurethane elastomer tire technologies. Amerityre is commercializing its technologies through licensing agreements with strategic partners, co-development projects and the sale of equipment and its proprietary chemical formulations.